WeLeader Biomedical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	296.84	174.97	94.69	100.73	111.52
Short-Term Investments	71.1	34.37	7.83	8.4	4.18
Trading Asset Securities	2.88	2.83	2.43	2.33	3.01
Cash & Short-Term Investments	370.81	212.17	104.95	111.45	118.71
Cash Growth	253.32%	102.16%	-5.83%	-6.11%	-
Accounts Receivable	270.58	276.87	273.63	279.43	290.68
Other Receivables	0	0.02	0.05	0.1	1.03
Receivables	270.58	276.89	273.69	279.52	291.71
Inventory	116.1	99.06	69.67	62.73	55.89
Other Current Assets	2.99	3.2	2.11	1.02	2.11
Total Current Assets	760.47	591.32	450.42	454.73	468.42
Property, Plant & Equipment	1,369	1,341	1,194	1,086	351.66
Long-Term Investments	27.19	26.82	42.87	27.84	29.6
Other Intangible Assets	3.27	4.06	3.88	5.74	6.13
Long-Term Deferred Tax Assets	0.5	0.46	0.69	0.79	0.49
Other Long-Term Assets	34.35	34.63	36.02	25.24	26.8
Total Assets	2,195	1,998	1,728	1,600	883.09
Accounts Payable	203.28	183.54	143.19	155.28	160.65
Accrued Expenses	42.39	56.82	55.27	48.18	44.01
Short-Term Debt	-	80	57	121.03	53
Current Portion of Long-Term Debt	17.95	17.44	16.97	15.02	13.63
Current Portion of Leases	90.05	81.43	74.62	49.75	53.93
Current Income Taxes Payable	35.82	25.54	23.87	34.46	23.84
Current Unearned Revenue	1.42	1.52	0.34	0.7	1.95
Other Current Liabilities	163.95	22.71	30.43	14.13	12.81
Total Current Liabilities	554.86	469.01	401.69	438.54	363.81
Long-Term Debt	393.09	397.96	249.03	270.23	18.65
Long-Term Leases	208.31	219.94	228.38	245.22	142.99
Long-Term Deferred Tax Liabilities	-	-	-	-	0
Other Long-Term Liabilities	2.69	2.69	2.69	0.2	0.22
Total Liabilities	1,159	1,090	881.78	954.19	525.68
Common Stock	454.79	415.79	415.79	342.46	193.49
Additional Paid-In Capital	341.94	141.13	141.13	92.96	8.73
Retained Earnings	238.96	351.16	276.57	213.89	155.2
Comprehensive Income & Other	0.39	0.39	12.29	-3.01	-
Shareholders' Equity	1,036	908.47	845.78	646.3	357.41
Total Liabilities & Equity	2,195	1,998	1,728	1,600	883.09
Total Debt	709.4	796.77	626	701.25	282.19
Net Cash (Debt)	-338.59	-584.6	-521.05	-589.79	-163.49
Net Cash Per Share	-8.03	-14.01	-12.68	-19.38	-5.82
Filing Date Shares Outstanding	45.48	41.58	41.59	34.25	27.88
Total Common Shares Outstanding	45.48	41.58	41.59	34.25	27.88
Working Capital	205.61	122.31	48.73	16.19	104.61
Book Value Per Share	22.78	21.85	20.34	18.87	12.82
Tangible Book Value	1,033	904.41	841.9	640.56	351.28
Tangible Book Value Per Share	22.71	21.75	20.24	18.70	12.60
Land	652.61	652.61	652.61	657.23	4.62
Buildings	-	-	-	11.93	11.93
Machinery	19.46	19.46	28.53	25.97	24.65
Construction In Progress	354.31	318.14	144.95	7.43	0.38

Source: S&P Global Market Intelligence. Standard template. Financial Sources.